Prof. Dr. Taner Demirer

Uluslararası Araştırma Makaleleri

1990 (yayın yılı)

1. (*) Demirer T, Icli F, Uzunalimoglu O, Kucuk O: Diet and Stomach Cancer Incidence.A case control study in Turkey."CANCER", Vol:65, No:10, pp:2344-2348,1990.

1993 (yayın yılı)

2. (*) Kucuk O, Demirer T, Gilman-sachs, Taw I, Mangold M, Singh S and Westerman M P: Intratumor heterogeneity of DNA ploidy and correlations with clinical stage and histologic grade in prostate cancer."JOURNAL of SURGICAL ONCOLOGY"Vol:54, pp:171-174, 1993.

1994 (yayın yılı)

3. (*) Demirer T, Dail D, and Aboulafia D : Four varied cases of intravascular lymphomatosis. "CANCER", March 15,Volume 73, No.6, pp: 1738-1745, 1994.

4. (*) Bensinger W, Demirer T, and Buckner C.D: Factors influencing stem cell mobilization and engraftment kinetics after transplantation of peripheral blood stem cells (PBSC's).Recent advances in hematopoietic stem cell transplantation-clinical progress, new technologies and gene therapy.University of California, San Diego School of Medicine.Book, pp: 109-116, March 10-12, 1994.

5. (*) Demirer T, Buckner C.D, Lilleby K, Weaver CH, Longin K, Appelbaum F, Bensinger W: Failure of a single cycle of high dose cyclophosphamide followed by intensive myeloablative therapy and autologous stem cell transplantation to improve outcome in relapsed disease."CANCER" Vol:74, no.2, pp:715-721,1994.

6. (*) Demirer T, Ravits J, Aboulafia D: Lambert-Eaton Myasthenic Syndrome associated with pulmonary large cell neuroendocrine carcinoma."SOUTHERN MEDICAL JOURNAL", Vol:87, No:11, pp:1186-1189,1994.

1995 (yayın yılı)

7. (*) Demirer T, Uzunalimoglu O, Koethe S, Kucuk O, McFadden W.P, Uzunalimoglu B, Anderson T: Flow cytometric measurement of proliferation-associated nuclear antigen P105 and DNA content in immuno-proliferative small intestinal disease."JOURNAL OF SURGICAL ONCOLOGY", Vol:58, No:1, pp:25-30, (January), 1995.

8. (*) Aboulafia D, Demirer T: Diffuse Myelonecrosis following Fludarabin administration in a patient with indolent lymphoma. "LEUKEMIA & LYMPHOMA", vol: 19, pp:181-184, 1995.

9. (*) Demirer T, Weaver CH, Buckner CD, Petersen FB, Bensinger WI, Sanders J, Clift RA, Anasetti C, Martin P, Storb R, Appelbaum FR: High-dose cyclophosphamide, carmustine, and etoposide (CBV) followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received dose-limiting radiation therapy."JOURNAL of CLINICAL ONCOLOGY", Vol:13, No:3 (March), page:596-602, 1995.

10. (*) Bensinger W.I, Weaver C.H, Appelbaum F.R, Rowley S, Demirer T, Sanders J.E, Storb R, Buckner C.D.Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor (rhG-CSF)."BLOOD", Vol:85, No:6, pages:1655-1658, 1995.

11. (*)Demirer T, Buckner C.D, Petersen F.B, Appelbaum F, Rowley S, Sanders J, Storb R, Benyunes MC, Fefer A, and Bensinger W. et al: Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte-colony stimulating factor (G-CSF) mobilized peripheral blood stem cells in patients with acute myelogenous leukemia. "BONE MARROW TRANSPLANTATION", Vol:15, No:6, pp:915-922, June 1995.

12. (*) Demirer T, Bensinger WI.Optimization of peripheral blood stem cell collections."CURRENT OPINION in HEMATOLOGY", Vol:2, No:3, pages:219-226, 1995.

13. (*) Demirer T, Gooley T, Buckner CD, Petersen FB, Lilleby K, Rowley S, Sanders J, Storb R, Appelbaum FR, Bensinger WI:The influence of total nucleated cell dose from marrow harvests on outcome in patients with acute myelogenous leukemia undergoing autologous transplantation."BONE MARROW TRANSPLANTATION",Vol:15, No:6, pp:907-913, June 1995.

14. (*) Demirer T, Petersen F.B, Appelbaum F.R, Sanders J.E, Deeg J, Storb R, Doney K, Bensinger W.I, Shannon-Dorcy K. and Buckner C.D.Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyper-fractionated total body irradiation in patients with advanced lymphoid malignancies-A phase I-II trial. "INTERNATIONAL J of RADIAT ONCOL BIOL. PHYS" Vol:32, No:4, pp:1103-1109, 1995.

15. (*) Demirer T, Rowley S, Buckner C.D, Appelbaum F.R., Lilleby K, Storb R, Bensinger W.I. Peripheral blood stem cell (PBSC) collections after paclitaxel, cyclophosphamide and recombinant human granulocyte-colony stimulating factor in patients with breast and ovarian cancer."JOURNAL OF CLINICAL ONCOLOGY", Vol:13, No:7, pp:1714-1719, July 1995.

16. (*) Bensinger WI, Appelbaum F, Rowley S, Storb R, Sanders J, Gooley T, Demirer T, Schiffman K, Weaver C, Clift R, Chauncey T, Klarnet J, Montgomery P, Petersdorf S, Weiden P, Witherspoon R, and Buckner CD:Factors that influence collection and engraftment of autologous peripheral blood stem cells."JOURNAL OF CLINICAL ONCOLOGY" Vol:13, No:10, pp:2547-2555, October 1995.

17. (*) Bensinger WI, Demirer T, Rowley S, Buckner CD:Factors predictive of rapid engraftment after peripheral blood stem cell infusions."BONE MARROWTRANSPLANTATION" Vol:15, Suppl:3, pages: 83-85, 1995.

18. (*) Bensinger WI, Appelbaum FR, Demirer T, Torok-Storb B, Storb B, Buckner CD:Transplantation of allogeneic peripheral blood stem cells."STEM CELLS" Vol:13 (Suppl 3), pp 63-70, 1995.

1996 (yayın yılı)

19. (*) Bensinger WI, Clift RA, Anasetti C, Appelbaum FR, Demirer T, Rowley S, Sandmaier BM, Torok-Storb B, Storb R, and Buckner CD:Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor."STEM CELLS" Vol:14, No:1, pages:90-105, 1996.

20. (*) Demirer T, Buckner CD, Bensinger WI: Optimization of peripheral blood stem cell mobilization."STEM CELLS" Vol:14, No:1, pages:106-116, 1996.

21. (*) Bensinger WI, Buckner CD, Rowley S, Demirer T, Storb R, and Appelbaum FR.Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.‘BONE MARROW TRANSPLANTATION’ Vol:17 (Suppl.2): S 38-39, 1996.

22. (*) Bensinger WI, Buckner CD, Demirer T, Storb R, Appelbaum FR.Transplantation of allogeneic peripheral blood stem cells, Proceedings of the First ınternational Symposium on Allogeneic Peripheral Blood Progenitor Cell Transplantation, An EBMT Symposium.‘BONE MARROW TRANSPLANTATION’ Vol:17 (Suppl.2): S56-S57, 1996.

23. (*) Demirer T, Buckner CD, Appelbaum FR, Lambert K, Bensinger WI, Clift R, Storb R, Slattery JT:Busulfan, cyclophosphamide and fractionated total body irradiation for allogeneic marrow transplantation for advanced acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels. ‘BONE MARROW TRANSPLANTATION" Vol:17, pages:341-346, 1996.

24. (*) Demirer T, Buckner CD, Appelbaum FR, Clift R, Storb R, Myerson D, Lilleby K, Rowley S, Bensinger WI:High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer. "BONE MARROW TRANSPLANTATION", Vol:17, pp:769-774, 1996.

25. (*) Demirer T, Buckner CD, Appelbaum FR, Bensinger WI, Sanders J, Lambert K, Clift R, Fefer A, Storb R, Slattery JT: Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: Phase I dose escalation of busulfan based on targeted plasma levels. "BONE MARROW TRANSPLANTATION", Vol: 17, pp:491-495, 1996.

26. (*) Schiffman K, Bensinger WI, Appelbaum FR, Rowley S, Lilleby K, Clift R, Weaver CH, Demirer T, Sanders J, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet JP, Trueblood K, Storb R, Buckner CD: Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease."BONE MARROW TRANSPLANTATION", Vol: 17, pp:943-950, 1996.

27. (*) Brunvand MW, Appelbaum FR, Soll E, Lilleby K, Clift R, Gooley T, Bensinger WI, Weaver CH, Rowley SD, Fefer A, Press OW, Storb R, Sanders J, Martin PL, Chauncey T, Maziarz RT, Weiden P, Demirer T, Holmberg LA, Schiffman K, McSweeney PA, Maloney DG, Buckner CD: High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: Comparison of autologous bone marrow and peripheral blood stem cells. "BONE MARROW TRANSPLANTATION", Vol:18,pp: 131-141, 1996.

28. (*) Bensinger WI, Rowley SD, Demirer T, Appelbaum FR, Lilleby K, Schiffman K, Clift RA, Barnett T, Storb R, Chauncey T, Maziarz RT, Klarnet J, Gooley TA, Fefer A, McSweeney PA, Holmberg L, Maloney DG, Weaver CH, Buckner CD:High-dose therapy followed by autologous hematopoietic stem cell infusion for patients with multiple myeloma."JOURNAL OF CLINICAL ONCOLOGY", Vol:14, No:5, pp:1447-1456, 1996.

29. (*) Demirer T, Buckner CD, Gooley T, Appelbaum FR, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger WI:Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma."BONE MARROWTRANSPLANTATION", Vol:17, pp:937-941, 1996.

30. (*) Demirer T, Petersen FB, Bensinger WI, Appelbaum FR, Fefer A, Rowley S, Sanders J, Chauncey T, Storb R, Lilleby K, Buckner CD:Autologous transplantation with peripheral blood stem cells collected after granulocyte-colony stimulating factor in patients with acute myelogenous leukemia."BONE MARROW TRANSPLANTATION", Vol: 18, pp:29-34, 1996.

31. (*) Bensinger WI, Demirer T, Buckner CD, Appelbaum FR, Storb R, Lilleby K, Weiden P, Bluming AZ, Fefer A:Syngeneic marrow transplantation in patients with multiple myeloma."BONE MARROW TRANSPLANTATION", Vol:18, pp. 527-531, 1996.

32. (*) Demirer T: Taxol with cyclophosphamide improves stem cell collection for autologous use."NATIONAL CANCER BULLETIN", pp:1-3, January-February, 1996.

33. (*) Bensinger WI, Clift R, Martin P, Demirer T, Sanders J, Buckner CD: Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies:A retrospective comparison with marrow transplantation.‘BLOOD’,Vol: 88, No:7, pp: 2794-2800, 1996.

34. (*) Bensinger WI, Buckner CD, Shannon-Dorcy K, Rowley S, Appelbaum FR, Benyunes M, CliftR,Mason P, Demirer T, Storb R, Lee M, Schiller G:Transplantation of allogeneic CD34+ peripheral blood stem cells (PBSC) in patients with advanced hematologic malignancy.BLOOD, Vol:88, No:11, pp:4132-4138, 1996.

1997 (yayın yılı)

35. (*) Demirer T, Buckner CD, Storer B, Appelbaum FR, Storb R, Bensinger WI:The effect of different chemotherapy regimens on peripheral blood stem cell mobilization yield. ’JOURNAL OF CLINICAL ONCOLOGY’, Vol 15, No:2, pp:684-690,1997.

36. Bensinger W.I, Weaver C.H, Appelbaum F.R, Rowley S, Demirer T, Sanders J.E, Storb R, Buckner C.D.Hot Papers-Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony stimulating factor . ’SCIENTIST’ vol:11, No:2, pp 15-16, 1997

1998 (yayın yılı)

37. (*) Williams O, Demirer T, Lilleby K, Buckner CD, Bensinger WI.Tempo of hematologic recovery correlates with peripheral blood CD34+ cell level in patients undergoing stem cell mobilization.J. CLINAPHERESISVol:13, pp1-6, 1998.

38. (*) Dilek I, Demirer T, Üstün C, Arat M, Koç H, Beksaç M, Erdi H, Anadolu R, Özcan M, İlhan O, Akan H:Acquired icthyosis associated with chronic graft-versus-hostdisease following an allogeneic peripheral blood stem cell transplantation in a patient with chronic myelogenous leukemia. ‘BONE MARROW TRANSPLANTATION’ Vol:21, pp: 1159-1161, 1998

39. (*) Dilek İ, Uysal A, Demirer T, Koç H, Özcan M, Keleş H, Numanoğlu N, Üstün C, Çiftçi E:Acute myeloblastic leukemia associated with hyperleukocytosis and diabetes insipidus.‘LEUKEMİA and LYMPHOMA’ Vol:30, pp: 657-660, 1998.

40. (*) Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI:High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell (PBSC) rescue in patients with advanced stage III-IV ovarian cancer.‘BONE MARROW TRANSPLANTATION’, Vol: 22, pp 651-659, 1998.

1999 (yayın yılı)

41. (*) Üstün C, Arslan Ö, Beksaç M, Koç H, Gürman G, Özçelik T, Yılmaz B, İlhan O, Akan H, Özcan M, Demirer T, Uysal A, Konuk N, Arat M, Dilek İ, Çelebi H, Şenol C:A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center, a focus on the incidence of GVHD and relapse.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, Vol:5, pp 28-35, 1999.

42. (*) Demirer T, Bensinger WI, Buckner CD: Peripheral Blood stem cell mobilization for high dose chemotherapy.‘JOURNAL OF HEMATOTHERAPY’, Vol:8, pp 103-113, 1999.

43. (*) Demirer T, Çelebi H, Arat M, Üstün C, Demirer S, Dilek İ, Özcan M, Ilhan O, Akan H, Gürman G, Koç H:Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation.‘BONE MARROW TRANSPLANTATION’, Vol:24, pp 335-337, 1999.

44. (*) Üstün C, Çelebi H, Arat M, Özcan M, Dilek İ, Gürman G, Demirer T, İlhan O, Keskin R, and Koç H.Treatment of aregeneratoric anemia following an ABO-incompatible allogeneic peripheral blood stem cell transplantation: A case report.‘THERAPEUTIC APHERESIS’Vol:3, No:3, pp 275-277, 1999.

45. Rosti G, Ferrante P, Crown J, Pıco JL, Leyvraz S, Ledermann J, Demirer T, Carıello A, Gıovanis P.High-dose chemotherapy and autologous stem cell transplantation in patients with breast cancer and other solid tumors.A review of the EBMT data.’TURKISH JOURNAL OF HEMATOLOGY’, Vol:16, No:3, pp. 19-26, (Suppl), 1999.

46. Demirer T, Arat M, Koç H, Üstün C, Özcan M, Gürman G, Arslan Ö, Çelebi H, İlhan O.Stem cell mobilization with cyclophosphamide, paclitaxel (or etoposide) and recombinant granulocytecolony stimülating factor (rhG-CSF): Ibn-I Sina experience. ’TURKISH JOURNAL OF HEMATOLOGY’, Vol:16, No:3, pp. 83-84, (Suppl), 1999.

47. (*) Demirer T, Çelebi H, Akçağlayan E, Üstün C, Demirer S, Ekinci C, Bahar K, Koç H.An interesting clinical picture of immünoproliferatif small intestinal disease (IPSID):Dıagnosis in oncology.‘JOURNAL OF CLINICAL ONCOLOGY’Vol:17, No:11, pp 3682-3684, 1999.

48. (*) Üstün C, Özcan M, Gürman G, Çakır M, Erekul S, Akyol G, Arat M, Çelebi H, İdilman R, Akan H, İlhan O, Demirer T, Beksaç M, Koç H:Differences in liver pathology and clinical outcomebetween two patients with hepatitis B virus and graft versus host disease.Pathology & Oncology Research, Vol:5, No:3, pp 229-232, 1999.

2000 (Yayın Yılı)

49. (*) Demirer T, Ilhan O, Mandel NM, Arat M, Günel N, Çelebi H, Üstün C, Akan H, Uysal A, Koç H:A phase-I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies.BONE MARROW TRANSPLANTATION, Vol:25, pp 697-703, 2000.

50.(*) Arslan Ö, Coşkun Ş, Arat M, Çelebi H, Özcan M, Gürman G, Demirer T, Akan H, İlhan O, Konuk N, Beksaç M, Uysal A, Koç H: Allogeneic peripheral blood stem cell transplantation for standard risk leukemias: Ibn-i Sina Experience. BONE MARROW TRANSPLANTATION, Vol:25, pp:1229-1232, 2000.

51. (*)Demirer S, Aydıntuğ S, Üstün C, Tüzün A, Başaran Ö, Türkmen E, Coşkun Ş, Çelebi H, Demirer T:Comparison of the efficacy of medium chain triglycerides with long chain triglycerides in TPN in patients with hematologic malignancies undergoing hematopoietic peripheral blood stem cell transplantation.CLINICAL NUTRITION, Vol:19, No:4, pp 253-258, 2000.

2001 (Yayın yılı)

52. (*) Demirer T, O. Ilhan, M. Arat, K. Dalva,M. Beksaç, H. Çelebi, C. Üstün, H. Akan, M. Özcan, G. Gürman, N. Konuk, A. Uysal, H. Koç: CD41+ and CD42+ hematopoietic progenitor cells predict platelet engraftment after allogeneic peripheral blood stem cell transplantation.JOURNAL OF CLINICAL APHERESIS, Vol: 16, pp 67-73, 2001.

53. (*) Özcan M, Üstün C, Akçağlayan E, Akan H, Arslan Ö, İlhan O, Beksaç M, Gürman G, Demirer T, Arat M, Çelebi H, Konuk N, Uysal A, Koç H.Recombinant human granulocyte colony-stimulating factor(rhG-CSF) may accelerate hematopoietic recovery after HLA identical sibling allogeneic peripheral blood stem cell transplantation.BONE MARROW TRANSPLANTATION, VoI: 27, pp 499-505, 2001.

2002 (Yayın Yılı)

54. Arat M, Ulusoy FV, Demirer T et al.Three cases of pericardial involvement of multiple myeloma.LEUKEMIA & LYMPHOMA, Vol: 43, Pp 145-148, 2002.

55. Demirer T, Aylı M,Ozcan M, Gunel N,Haznedar R,Dağlı M, Fen T,Genc Y, Dincer S, Arslan O, Gürman G, Demirer S,Özet G,Uysal A,Konuk N, İlhan O,Koc H, Akan H:Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte-colony stimulating factor (Rh-GSCF): A randomized evaluation of different doses of Rh-GSCF. BRITISH JOURNAL OF HAEMATOLOGY, Vol: 116, pp 468-472, 2002.

56. Demirer T, Daglı M, Ilhan O,Aylı M, Haznedar R, Fen T, Günel N, Genc Y, Arat M, Ozcan M, Arslan Ö, Seyrek E, Dincer S, Üstün T, Ustael N, Koc H, Müftüoğlu O, Akan H.A randomized trial of assessment of efficacy of leukapheresis volumes, 8 liters vs 12 liters.BONE MARROW TRANSPLANTATION, Vol: 29, pp 893-897, 2002.

57. Arslan O, Coşkun HŞ, Arat M, Soydan E, Özcan M, Gürman G, Çelebi H, Demirer T, Akan H, Ilhan O, Konuk N, Uysal A, Beksac M, Koc H.The role of ABO incompatibility in allogeneic peripheral blood stem cell transplantation.TURK J HAEMATOL, Vol: 19(3):401-409, 2002.

58. Demirer T,İlhan O, Aylı M,Arat M, Daglı M,Özcan M, Haznedar R, Genç Y, Fen T, Ayyılldız E, Dincer S, Arslan Ö, Gürman G,Konuk N, Dalva K, Uysal A, Koç H, Özet G,Akan H.Monitoring of peripheral blood CD34+ cell counts on the first day of apheresis is highly predictive for efficient CD34+ cell yield. THERAPEUTIC APHERESIS, October, Vol:6 (5), pp 384-389, 2002.

59. Demirer T, Aylı M, Daglı M, Haznedar R, Genc Y, Fen T, Dincer S, Ünal E, Günel N, Seyrek E, Üstün T, Ustael N, Yıldız M, Sertkaya D, Ozet G, Müftüoğlu O.Influence of post-transplant recombinant human granulocyte-colony stimulating factor administration on peritransplant morbidity in patients undergoing autologous stem cell transplantation.BRITISH JOURNAL OF HAEMATOLOGY, Vol:118, pp 1104-1111, 2002.

60. Demirer T, Aylı M, Daglı M, Fen T, Haznedar R, Ustael N, Ustun T, Oymak A, Ozdel O, Müftüoğlu O.The effect of post-transplant spironolactone on daily potassium requirements in patients undergoing autologous stem cell transplantation. BONE MARROW TRANSPLANTATION, Vol: 30, pp 703-706, 2002.

61. Daglı M, Demirer T, Aylı M, Haznedar R, Günel N, Sucak G, Fen T, Moran M, Üstün T, Aybirdi C, Çavuşoglu M, Dincer S, Uysal A.Plasmacytoma in the bilateral breast.TURK J HAEMATOL, Vol: 19 (4): 477-480, 2002.

2003 (Yayın Yılı)

62. Demirer T, VA Uysal, Ayli M, Genc Y, Ilhan O, Koc H, Dagli M, Arat M, Gunel N, Fen T, Dincer S, Ustael N, Yildiz M, Ustun T, Seyrek E, Ozet G, Muftuoglu O, Akan H.High-dose thiotepa, melphalan, and carboplatin, (TMCb) followed by autologous stem cell transplantation in patients with advanced breast cancer: a retrospective evaluation. BONE MARROW TRANSPLANTATION, Vol: 31, 755-761, 2003.

63. Kröger N, Zander AR, Martinelli G, Ferrante P, Moraleda JR, Zambelli A, Lelli G, Blaise D, Demirer T, Socie G, Rosti G, on behalf of EBMT Solid Tumors Working Party.Low incidence of secondary myelodysplasia (sMDS) and acute myeloid leukemia (sAML) after high-dose chemotherapy as adjuvant therapy for breast cancer patients: A study of the working party ‘Solid Tumors’ of the European Group for Blood and Marrow Transplantation (EBMT).ANNALS OF ONCOLOGY, 14, 554-558, 2003.

64. Pedrazzoli P, Ferrante P, Kulekci A, Schiavo R, Giorgi UD, Carminati O, Marangolo M, Demirer T, Siena S, Rosti G on behalf of the European Group for Blood and Marrow Transplantation (EBMT), Solid Tumors Working Party.Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990-1999.BONE MARROW TRANSPLANTATION, Vol:32, 489-494, 2003.

65. Demirer T .(Book Chapter).CD 34+ Cells in Hematopoietic Stem Cell Transplantation. Chapter 8, pp 107-118. In TISSUE ENGINEERING, STEM CELLS, AND GENE THERAPIES. (Advances in Experimental Mmedicine and Biology, Volume 534).Edited by: M Elçin, Kluwer Academic/Plenum Publishers, New York, 2003.

66. Kröger N, Damon L, Zander A R, Wandt H, Derigs G,Ferrante P, Demirer T, Rosti G on behalf of the EBMT Solid Tumors Working Party.Secondary acute leukemia following mitoxantrone based high-dose chemotherapy for primary breast cancer patients.BONE MARROW TRANSPLANTATION, 32, 1153-1157, 2003.

67. Rosti G, Demirer T, Giorgi U D, Kramar A, Droz JP, Biron P, on behalf of EBMT-STWP and IT-94 study.Advanced Germ cell tumors: The EBMT experience and the IT-94 study.(Book Chapter) ABMT XI-Chapter 4-Solid Tumors, 2003.

2004 (Yayın yılı)

68. Demirer T.The EBMT Handbook. Haemopoietic Stem Cell Transplantation.European School of Haematology. (Book Chapter) Editors: J Apperley, A Gratwohl.Chapter 16.4 : Solid Tumors, Page: 277, 2004.

69. Gratwohl A, Baldomero H, Demirer T, Rosti G, Dini G, Ladenstein R, Urbano-Ispizua A.Hematopoetic Stem cell transplantation for solid tumors in Europe.ANNALS OF ONCOLOGY, Apr; 15 (4): 653-60, 2004.

70. Demirer T, Ayli M, Fen T, Ozcan M, Arat M, Büyükberber S, Arslan Ö, Gürman, Akan H, Ilhan O. High-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation in patients with lmphoma: A retrospective evaluation.BONE MARROW TRANSPLANTATION, 34, 781-786, 2004.

71. Demirer T.Autologous stem cell transplantation and allogeneic non-myeloablative transplants in solid tumors.International Journal of Hematology-Oncology & Bone Marrow Transplantation, Vol:1, No:3, pp: 4-8, 2004.

72. Giorgi U D, Wandt H, Lioure B, Leyvraz S, Papiani G, Ballardini M, Kulekci A, Demirer T.First-line high-dose chemotherapy for patients with poor prognosis extragonadal germ cell tumors. The experience of the European Bone Marrow Transplantation (EBMT) Solid Tumors Working party. BONE MARROW TRANSPLANTATION, Dec;34 (12): 1033-1037, 2004.

2005 (Yayın Yılı)

73. Giorgi U De, Demirer T, Wandt H, Taverna C, Siegert W, Bornhauser M, Kozak T, Papiani G, Ballardini M, Rosti G. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary nonseminomatous germ cell tumors: the EBMT experience.ANNALS OF ONCOLOGY, vol: 16, Pp: 146-151,2005.

74. Bengala C, Guarneri V, Ledermann J, Rosti G, Wandt H, Lotz JP, Cure JH, Orlandini C, Ferrante P, Conte PF, Demirer T on behalf of EBMT Solid Tumor Working Party.High-dose chemotherapy with autologous hemopoietic support for advanced ovarian cancer in first complete remission: retrospective analysis from the Solid Tumor Registry of the European Group for Blood and marrow Transplantation (EBMT).BONE MARROW TRANSPLANT, vol, 36, pp 25-31, 2005.

75. Giorgi U De, Rosti G, Slavin S, Yaniv I, Harousseau JL, Ladenstein R, Demirer T, Dini G, on behalf of the European Group for Blood and Marrow Transplantation, Solid Tumours and pediatric disease working parties.Salvage high-dose chemotherapy for children with extragonadal germ cell tumours, .BRITISH JOURNAL of CANCER, vol: 93, No: 4, pp 412-417, 2005.

76. Peccatori J,Barkholt L,Demirer T,Sormani M.P,Bruzzi P,Ciceri F,Zambelli A,Da Prada GA,Pedrazzoli P,Siena S,Massenkeil G,Martino R,Lenhoff S,Corradini P,Rosti G,Ringden O,Bregni M andNiederwieser D, on behalf of EBMT Solid Tumor Working Party.Prognostic factors for survival in patients with advanced renal cell cancer undergoing non-myeloablative allogeneic stem cell transplantation.CANCER , Vol: 104, No: 10, pages: 2099-2103, 2005.

2006 (Yayın Yılı)

77. Ljungman P, Urbano-Ispizua A, Cavazzini-Calvo M, Demirer T, Dini G, Einsele H, Gratwohl A, Madrigal A, Niederwieser D, Passweg J, Rocha V, Saccardi R, Schouten H, Socie G, Sureda A, and Apperley J for the European Group for Blood and Marrow Transplantation. Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in Europe.BONE MARROW TRANSPLANT, 37 (5), 439-49, 2006.

78. Barkholt L,Bregni M,Remberger M,Blaise D,Peccatori J,Massenkiel G,Pedrazzoli P,Zambelli A,Bay J. O,Francois S,Martino R,Bengala C,Brune M,Lenhoff S,Porcellini A,Falda M,Siena S, Demirer T,Niederwieser D andRingdén O.On behalf of the EBMT Solid Tumour Working Party. European experience of allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma.ANNALS OF ONCOLOGY, Vol: 17, pp1134-1140, 2006.

79. Pedrazzoli P, Ledermann JA, Lotz JP, Leyvraz S, Aglietta M, Rosti G, Champion K, Secondino S, Selle F, Ketterer N, Grignani G, Siena S, Demirer T, on behalf of the EBMT Solid Tumors Working Party.High-dose chemotherapywith autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults. ANNALS OF ONCOLOGY, Vol: 17 (10), pp 1479-1488, 2006

2007 (yayın yılı)

80. Bay JO, Linassier C, Biron P, Durando X, Verrelle P, Rosti G, Demirer T, for the EBMT Solid Tumors Working Party. Does high-dose BCNU increase overall survival in supratentorial high-grade malignant gliomas? An EBMT retrospective study. INTERNATIONAL JOURNAL OF CANCER, Vol:120, issue 8, pp 1782-86, 2007

81. Secondino S, Carrabba MG, Pedrazzoli P, Castagna L, Spina F, Grosso F, Bertuzzi A, Bay JO, Siena S, Corradini P, Niederwieser D, Demirer T. Reducued intensity stem cell transplantation for advanced soft tissue sarcomas in adults: a retrospective analysis of the European Group for Blood and Marrow Transplantation. HAEMATOLOGICA, Vol:92, pp 418-20, 2007.

82. Pedrazzoli P, Rosti G, Secondino S, Carminati O, Demirer T, on behalf of the European Group for Blood and Marrow Trasplantation (EBMT), Solid Tumors Working Party and Gruppo Italiano di Trapianto Midollo Osseo (GITMO). High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors in adults. SEMINARS IN HEMATOLOGY, Vol:44, pp 286-295, 2007.

83. Giorgi UD, Blaise D, Lange A, Viens P, Marangolo M, Madroszyk A, Brune M, Afanassiev BV, Rosti G, and Demirer T. High-dose chemotherapy with peripheral blood progenitor cell support for patients with non-small cell lung cancer: the experience of the European Group for Bone Marrow Transplantation (EBMT) Solid Tumours Working Party. BONE MARROW TRANSPLANTATION, Vol: 40, pp 1045-1048, 2007.

2008 (yayın yılı)

84. Demirer T, Barkholt L, Blaise D, Pedrazzoli P, Aglietta M, Carella AM, Bay JO, Arpacı F, Rosti G, Gurman G, Niederwieser D, Bregni M, on behalf of the EBMT Solid Tumors Working Party. Transplantation of allogeneic hematopoietic stem cells: an emerging treatment modality for solid tumors. NATURE CLINICAL PRACTICE ONCOLOGY, Vol: 5, No: 5, pp 256-267, 2008.

85. İlhan O, Topçuoğlu P, Arat M, Soydan EA, Yuksel MK, Arslan Ö, Özcan M, Gürman G, Demirer T, Akan H, Konuk N, Uysal A. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloblastic leukemia (AML): A single center experience, TURK J HAEMATOL Pages 87 – 93, Vol:25, ıssue 2, 2008.

86. Ueno N T, Rizzo D, Demirer T, Cheng YC, Hegenbart U, Zhang MJ, Bregni M, Rondon G, Champlin RE, Antman K, Stiff PJ, Horowitz MM, Niederwieser D. Allogeneic hematopoietic cell transplantation for metastatic breast cancer. BONE MARROW TRANSPLANT, Vol: 41, pp 537-545, 2008.

87. Ladenstein R, Pötschger U, Hartman O, Pearson ADJ, Klingebiel, Castel V, Yaniv I, Demirer T, and Dini G, on behalf of the EBMT Paediatric Working Party. 28 years of hıgh-dose therapy and SCT for neuroblastoma in Europe: lessons from more than 4000 procedures. BONE MARROW TRANSPLANTATION, Vol: 41, S 118-127, 2008.

2009 Yılı

88. Aglietta M, Barkholt L, Carnevale Schianca F Caravelli D, Omazic B, Minotto C, Leone F, Hentschke P. Bertoldero G , Capaldi A, Ciccone G, Niederwieser D, Ringdén O, Demirer T, On behalf of the EBMT Solid Tumor Working Party. Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantation in Metastatic Colorectal Cancer as a Novel Adoptive Cell Therapy Approach. The European Group for Blood and Marrow Transplantation Experience. BIOLOGY of BLOOD and MARROW TRANSPLANTATION, Vol:15, pages 326-335, 2009.

89. Aktaş B, Topcuoglu P, Kurt ÖK, Ensari A, Demirer T. Severe Henoch-Schönlein Purpura induced by Cytarabine. THE ANNALS OF PHARMACOTHERAPY, Letter, vol: 43 (4), pp 792-3, 2009.

90.Ozcelik T, Topcuoglu P, Beksac M, Ozcan M, Arat M, Bıyıklı Z, Bakanay SM, Ilhan O, Gurman G, Arslan O, Demirer T. Mobilization of PBSCs with chemotherapy and recombinant human G-CSF: a randomized evaluation of early vs late administration of recombinant human G-CSF. BONE MARROW TRANSPLANTATION , Vol: 44, No:12, pp 779-783, 2009.

91.
Bay JO, Cabrespine-Faugeras A, Tabrizi R, Blaise D, Viens P, Ehninger G, Bornhauser M,Slavin S, Rosti G, Demirer T, Bregni M. Allogeneic stem cell transplantation in ovarian cancer. The EBMT Experience. In Press INT. J. CANCER

^Başa Dön